Ziihera GEA Trial: Modest Gains Come With Severe Side Effects

Jazz new stomach cancer drug extends survival by 7 months but causes severe side effects in 25% of patients. Ziihera-only combination failed to achieve statistical significance for overall survival at first analysis.